PL2242492T3 - Środki przeciwnowotworowe o strukturze benzofenantrydyny oraz preparaty je zawierające - Google Patents

Środki przeciwnowotworowe o strukturze benzofenantrydyny oraz preparaty je zawierające

Info

Publication number
PL2242492T3
PL2242492T3 PL09712902T PL09712902T PL2242492T3 PL 2242492 T3 PL2242492 T3 PL 2242492T3 PL 09712902 T PL09712902 T PL 09712902T PL 09712902 T PL09712902 T PL 09712902T PL 2242492 T3 PL2242492 T3 PL 2242492T3
Authority
PL
Poland
Prior art keywords
benzophenanthridine
formulations containing
antitumoral agents
antitumoral
agents
Prior art date
Application number
PL09712902T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Paolo Morazzoni
Antonella Riva
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PL2242492T3 publication Critical patent/PL2242492T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09712902T 2008-02-22 2009-02-16 Środki przeciwnowotworowe o strukturze benzofenantrydyny oraz preparaty je zawierające PL2242492T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000284A ITMI20080284A1 (it) 2008-02-22 2008-02-22 Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
PCT/EP2009/001079 WO2009103476A1 (en) 2008-02-22 2009-02-16 Antitumoral agents with a benzophenanthridine structure and formulations containing them
EP09712902.7A EP2242492B1 (en) 2008-02-22 2009-02-16 Antitumoral agents with a benzophenanthridine structure and formulations containing them

Publications (1)

Publication Number Publication Date
PL2242492T3 true PL2242492T3 (pl) 2015-02-27

Family

ID=40291684

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09712902T PL2242492T3 (pl) 2008-02-22 2009-02-16 Środki przeciwnowotworowe o strukturze benzofenantrydyny oraz preparaty je zawierające

Country Status (16)

Country Link
US (1) US8337903B2 (pl)
EP (1) EP2242492B1 (pl)
JP (1) JP5693970B2 (pl)
KR (1) KR101633717B1 (pl)
CN (1) CN101951907A (pl)
AU (1) AU2009217020B2 (pl)
CA (1) CA2716019C (pl)
DK (1) DK2242492T3 (pl)
ES (1) ES2496669T3 (pl)
IL (1) IL207683A (pl)
IT (1) ITMI20080284A1 (pl)
PL (1) PL2242492T3 (pl)
PT (1) PT2242492E (pl)
RU (1) RU2492862C2 (pl)
SI (1) SI2242492T1 (pl)
WO (1) WO2009103476A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20080038A1 (it) * 2008-01-11 2009-07-12 Indena Spa Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CN102764259A (zh) * 2011-05-03 2012-11-07 中国科学院动物研究所 血根碱类化合物在制备防治癌症的药物中的用途和药物组合物
EP2759201B1 (en) 2012-04-03 2017-08-23 The Shizuoka Chamber of Commerce and Industry Composition for improving resistance to environmental stress of plant and method for improving resistance to environmental stress of plant
CN102887904B (zh) * 2012-10-10 2015-01-14 广西师范大学 2,3-二氧乙基-5-甲基-8,9-二甲氧基苯并菲啶衍生物及其制备方法和应用
KR102456075B1 (ko) 2015-10-15 2022-10-19 삼성디스플레이 주식회사 화합물 및 이를 포함하는 유기 발광 소자
CN110339171A (zh) * 2018-04-03 2019-10-18 临沂大学 一种白屈菜红碱固体分散体
CN111467347A (zh) * 2020-04-30 2020-07-31 河北医科大学第二医院 苯并菲啶生物碱类化合物用于制备ano1 编码的钙激活氯离子通道阻断剂的用途
KR102893442B1 (ko) * 2022-12-23 2025-12-01 가톨릭대학교 산학협력단 켈레리트린 클로라이드 또는 그의 약제학적으로 허용가능한 염을 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
CN118717764B (zh) * 2024-06-21 2025-01-24 中国人民解放军空军军医大学 白屈菜红碱、白屈菜碱联合血根碱在制备癌症治疗药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4769452A (en) * 1986-02-07 1988-09-06 Vipont Laboratories, Inc. Production of purity benzo-c-phenanthridine alkaloid salts
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
GB9211659D0 (en) * 1992-06-02 1992-07-15 Indena Spa New alkaloid derivatives,their use and pharmaceutical formulations containing them
US6025365A (en) * 1997-03-25 2000-02-15 Arch Development Corp. Chelerythrine and radiation combined tumor therapy
JP2000109428A (ja) * 1998-10-05 2000-04-18 Taisho Pharmaceut Co Ltd 咽頭粘膜用組成物
CH695417A5 (de) 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (en) * 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
ES2226567B1 (es) * 2003-06-20 2006-07-01 Universidad De Santiago De Compostela Nanoparticulas de acido hialuronico.
US20070166388A1 (en) * 2005-02-18 2007-07-19 Desai Neil P Combinations and modes of administration of therapeutic agents and combination therapy
ITMI20080284A1 (it) 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono

Also Published As

Publication number Publication date
CA2716019C (en) 2016-07-05
JP5693970B2 (ja) 2015-04-01
DK2242492T3 (da) 2014-09-15
RU2492862C2 (ru) 2013-09-20
EP2242492B1 (en) 2014-07-23
WO2009103476A1 (en) 2009-08-27
PT2242492E (pt) 2014-09-04
WO2009103476A8 (en) 2009-12-03
AU2009217020A1 (en) 2009-08-27
RU2010134570A (ru) 2012-02-27
CN101951907A (zh) 2011-01-19
IL207683A0 (en) 2010-12-30
IL207683A (en) 2014-04-30
CA2716019A1 (en) 2009-08-27
KR101633717B1 (ko) 2016-06-27
JP2011512370A (ja) 2011-04-21
KR20100119551A (ko) 2010-11-09
ITMI20080284A1 (it) 2009-08-23
US8337903B2 (en) 2012-12-25
SI2242492T1 (sl) 2014-10-30
AU2009217020B2 (en) 2013-11-28
US20100331525A1 (en) 2010-12-30
EP2242492A1 (en) 2010-10-27
ES2496669T3 (es) 2014-09-19

Similar Documents

Publication Publication Date Title
IL207683A0 (en) Antitumoral agents with a benzophenanthridine structure and formulations containing them
SI2318366T1 (sl) Psma-vezavna sredstva in njihova uporaba
ZA201101896B (en) Frizzled-binding agents and uses thereof
GB2447532B (en) Devices and methods for use in construction
DK3275894T3 (en) Antagonistisk cxc-chemokin-receptor-4(cxcr4)-polypeptid
PL2313395T3 (pl) Analogi pirydonu i pirydazonu jako modulatory GPR119
GB0806653D0 (en) A supporting structure and a workstation incorporating the supporting structure
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
EP2162534A4 (en) METHOD AND COMPOSITIONS RELATED TO CD34 STEM CELLS
ZA201003696B (en) Compositions and devices
EP2307052A4 (en) ANTI-BETA-2-MICROGLOBULIN AGENTS AND THEIR USE
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
EP2167096A4 (en) IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
TWI367763B (en) Compositions and devices
GB0801682D0 (en) Delivery device and kit
ZA200903049B (en) Polymer-linked-bisphosphonate inhalant formulations and methods for using the same
EP2148719A4 (en) DEVICES AND METHODS FOR DRUG DELIVERY
EP2252305A4 (en) OMENTUM AND ITS USE
GB2461611B (en) Composition and use thereof
EP2348865A4 (en) BETA-HYDROXY-GAMMA-AMINOPHOSPHONATES, THEIR METHODS OF PREPARATION AND THEIR USE
TWI366394B (en) Synchronnization devices and methods
GB2468142B (en) Valve devices and associated accessories and assemblies
HU0800405D0 (en) Ewnvironment-friendly biocidis and use thereof
GB0813734D0 (en) Com-fee 2 in 1
GB0810409D0 (en) Composition and use thereof